60 Biggest Movers From Friday
Gainers
Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share.
Sphere 3D Sponsored SPAC Minority Equality Opportunities Acquisition Inc., Announces Pricing Of Upsized $110M Initial Public Offering
Sphere 3D Corp. (NASDAQ: ANY) ("Sphere 3D" or the "Company"), a company delivering containerization, virtualization, and data management solutions, today reports that Minority Equality OpportunitiesSphere 3D Corp.
Why Is Sphere 3D Stock Trading Higher Today?
Sphere 3D Corp (NASDAQ:ANY) and Gryphon Digital Mining inked an agreement to purchase an additional 250,000 Certified Emission Reductions (CERs or…
Sphere3D Reports Deal With Gryphon Digital Mining To Buy Added 250K Certified Emission Reductions, No Terms Disclosed
Gryphon Digital Mining ("Gryphon") and Sphere 3D Corp. (NASDAQ:ANY) ("Sphere 3D") today announced that they have entered into an agreement to purchase an additional 250,000 Certified
66 Biggest Movers From Yesterday
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
Why Bitcoin-Related Stock Sphere 3D Is Getting Hammered Today
Sphere 3D Corp (NASDAQ: ANY) shares are trading lower by 14.1% at $4.04 Tuesday afternoon after the company reported its second-quarter earnings results.
Sphere 3D reported quarterly losses of 19 cents per share and quarterly sales of $894,000.
Sphere 3D Yesterday Reported Q2 EPS $(0.19) Up From $(0.41) YoY, Sales $894.00K Up From $891.00K YoY
Sphere 3D (NASDAQ:ANY) reported quarterly losses of $(0.19) per share. This is a 53.66 percent increase over losses of $(0.41) per share from the same period last year. The company reported $894.00 thousand in sales
48 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA regarding MMS019.
25 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Cardiol Therapeutics Inc. (NASDAQ: CRDL) shares rose 25.8% to $3.27 in pre-market trading after dropping around 7% on Monday.